Endocannabinoid/GABA interactions in the entopeduncular nucleus modulates alcohol intake in rats

Brain Research Bulletin

Volumn 91, Issue , 2013, Pages 31-37

  Méndez Díaz, Mónica ^a   Caynas Rojas, Seraid ^a   Gómez Armas, David ^a   Ruiz Contreras, Alejandra E ^b   Aguilar Roblero, Raúl ^c   Prospéro García, Oscar ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b Laboratorio de Neurogenómica Cognitiva   (Mexico)

^c INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

Author keywords

Alcohol intake; Anandamide; Cannabinoid receptor 1; Entopeduncular nucleus; GABAB receptor

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 4 AMINOBUTYRIC ACID; ANANDAMIDE; BACLOFEN; CANNABINOID 1 RECEPTOR; TAP WATER;

ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRINKING BEHAVIOR; ENTOPEDUNCULAR NUCLEUS; MALE; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT;

ALCOHOL DRINKING; ALCOHOLISM; ANIMALS; ENDOCANNABINOIDS; ENTOPEDUNCULAR NUCLEUS; GABA AGONISTS; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; INJECTIONS, INTRAVENTRICULAR; MALE; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; SYNAPTIC TRANSMISSION;

EID: 84872414829     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2012.11.010     Document Type: Article

References (61)

1. Adamczyk P., Miszkiel J., McCreary A.C., Filip M., Papp M., Przegaliński E. The effects of cannabinoid CB1, CB2 and vanilloid TRPV1 receptor antagonists on cocaine addictive behavior in rats. Brain Research 2012, 1444:45-54.
2. Bakkali-Kassemi L., El Ouezzani S., Magoul R., Merroun I., Lopez-Jurado M., Errami M. Effects of cannabinoids on neuropeptide Y and β-endorphin expression in the rat hypothalamic arcuate nucleus. British Journal of Nutrition 2011, 105:654-660.
3. Becker H.C. Animal models of alcohol withdrawal. Alcohol Research and Health 2000, 24:105-113.
4. Bell R.L., Sable H.J., Colombo G., Hyytia P., Rodd Z.A., Lumeng L. Animal models for medications development targeting alcohol abuse using selectively bred rat lines. Neurobiological and Pharmacological Validity 2012, 103:119-155.
5. Berner L.A., Bocarsly M.E., Hoebel B.G., Avena N.M. Baclofen suppresses binge eating of pure fat but not a sugar-rich or sweet-fat diet. Behavioural Pharmacology 2009, 20:631-634.
6. Chávez A.E., Chiu C.Q., Castillo P.E. TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus. Nature Neuroscience 2010, 13:1511-1518.
7. Colombo G., Serra S., Brunetti G., Gomez R., Melis S., Vacca G., et al. Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring SP rats. Psychopharmacology 2002, 159:157-181.
8. Colombo G., Vacca G., Serra S., Carai M.A., Gessa G.L. Suppressing effect of the cannabinoid CB1 receptor antagonist, SR 141716, on alcohol's motivational properties in alcohol-preferring rats. European Journal of Pharmacology 2004, 498:119-123.
9. Crews F.T., Boettiger C.A. Impulsivity, frontal lobes and risk for addiction. Pharmacology Biochemistry and Behavior 2009, 93:237-247.
10. Díaz-Ruiz O., Navarro L., Méndez-Díaz M., Galicia O., Elder J.H., Sanna P.P., et al. Inhibition of the ERK pathway prevents HIVgp120-induced REM sleep increase. Brain Research 2001, 913:78-81.
11. de Bruin N.M., Lange J.H., Kruse C.G., Herremans A.H., Schoffelmeer A.N., van Drimmelen M., et al. SLV330, a cannabinoid CB(1) receptor antagonist, attenuates ethanol and nicotine seeking and improves inhibitory response control in rats. Behavioural Brain Research 2011, 217:408-415.
12. de Wit H. Impulsivity as a determinant and consequence of drug use: a review of underlying processes. Addiction Biology 2009, 14:22-31.
13. Eagle D.M., Baunez C., Hutcheson D.M., Lehmann O., Shah A.P., Robbins TW Stop-signal reaction-time task performance: role of prefrontal cortex and subthalamic nucleus. Cerebral Cortex 2008, 18:178-188.
14. Engler B., Freiman I., Urbanski M., Szabo B. Effects of exogenous and endogenous cannabinoids on GABAergic neurotransmission between the caudate-putamen and the globus pallidus in the mouse. Journal of Pharmacology and Experimental Therapeutics 2006, 316:608-617.
15. Fatseas M., Debrabant R., Auriacombe M. The diagnostic accuracy of attention-deficit/hyperactivity disorder in adults with substance use disorders. Current Opinion in Psychiatry 2012, 25:219-225.
16. Femenía T., García-Gutiérrez M.S., Manzanares J. CB1 receptor blockade decreases ethanol intake and associated neurochemical changes in fawn-hooded rats. Alcoholism, Clinical and Experimental Research 2010, 34:131-141.
17. Gallate J.E., Saharov T., Mallet P.E., McGregor I.S. Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist. European Journal of Pharmacology 1999, 370:233-240.
18. Gamaleddin I., Wertheim C., Coen K.M., Vemuri K., Makryannis A., Golberg S.R., et al. Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking. Addiction Biology 2011, 17:47-61.
19. Glass M., Dragunow M., Faul R.L. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 1997, 77:299-318.
20. 3H]GABA release in the globus pallidus of the rat when G(i) protein-receptor coupling is restricted: role of dopamine D2 receptors. Journal of Pharmacology and Experimental Therapeutics 2009, 328:822-828.
21. González S., Cascio A.G., Fernández-Ruiz J., Fezza F., Di Marzo V., Ramos J. Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine. Brain Research 2002, 954:73-81.
22. Gorsane M.A., Kebir O., Hache G., Blecha L., Aubin H.J., Reynaud M., Benyamina A. Is baclofen a revolutionary medication in alcohol addiction management? Review and recent updates. Substance Abuse 2012, 33:336-349.
23. Grueter B.A., Brasnjo G., Malenka R.C. Postsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens. Nature Neuroscience 2010, 13:1519-1525.
24. Hauber W. Involvement of basal ganglia transmitter systems in movement initiation. Progress in Neurobiology 1998, 56:507-540.
25. Herrera-Solis A., Vazquez K.G., Prospéro-García O. Acute and subchronic administration of anandamide or oleamide increases REM sleep in rats. Pharmacology Biochemistry and Behavior 2010, 95:106-112.
26. Howland R.H. Baclofen for the treatment of alcohol dependence. Journal of Psychosocial Nursing and Mental Health Services 2012, 50:11-14.
27. Joos L., Goudriaan A.E., Schmaal L., De Witte N.A., Van den Brink W., Sabbe B.G., et al. The relationship between impulsivity and craving in alcohol dependent patients. Psychopharmacology 2012, (Epub ahead of print).
28. Klavir O., Winter C., Joel D. High but not low frequency stimulation of both the globus pallidus and the entopeduncular nucleus reduces 'compulsive' lever-pressing in rats. Behavioural Brain Research 2011, 216:84-93.
29. Li F., Fang Q., Liu Y., Zhao M., Li D., Wang J., et al. Cannabinoid CB (1) receptor antagonist rimonabant attenuates reinstatement of ketamine conditions place preference in rats. European Journal of Pharmacology 2008, 589:122-126.
30. Loi B., Lobina C., Maccioni P., Fantini N., Carai M.A., Gessa G.L., Colombo G. Increase in alcohol intake, reduced flexibility of alcohol drinking, and evidence of signs of alcohol intoxication in Sardinian alcohol-preferring rats exposed to intermittent access to 20% alcohol. Alcoholism Clinical and Experimental Research 2010, 34:2147-2154.
31. Luchicchi A., Lecca S., Carta S., Pillolla G., Muntoni A.L., Yasar S., et al. Effects of fatty acidamide hydrolase inhibition on neuronal response to nicotine, cocaine and morphine in the nucleus accumbens shell and ventral tegmental area: involvement of PPAR-alpha nuclear receptors. Addiction Biology 2010, 15:277-288.
32. Maccioni P., Serra S., Vacca G., Orrù A., Pes D., Agabio R., et al. Baclofen-induced reduction of alcohol reinforcement in alcohol-preferring rats. Alcohol 2005, 36:161-168.
33. Malinen H., Hyytiä P. Ethanol self-administration is regulated by CB1 receptors in the nucleus accumbens and ventral tegmental area in alcohol-preferring AA rats. Alcoholism, Clinical and Experimental Research 2008, 32:1976-1983.
34. McDonald J., Schleifer L., Richards J.B., de Wit H. Effects of THC on behavioral measures of impulsivity in humans. Neuropsychopharmacology 2003, 28:1356-1365.
35. Méndez-Díaz M., Rueda-Orozco P., Ruiz-Contreras A.E., Prospéro-García O. The endocannabinoid system modulates the valence of the emotion associated to food ingestion. Addiction Biology 2012, 17:725-735.
36. Miner P., Borkuhova Y., Shimonova L., Khaimov A., Bodnar R.J. GABA-A and GABA-B receptors mediate feeding elicited by the GABA-B agonist baclofen in the ventral tegmental area and nucleus accumbens shell in rats: reciprocal and regional interactions. Brain Research 2010, 1355:86-96.
37. Orio L., Edwards S., George O., Parsons L.H., Koob G.F. A role for the endocannabinoid system in the increased motivation for cocaine in extended-access conditions. Journal of Neuroscience 2009, 29:4846-4857.
38. Patel S.M., Ebenezer I.S. The effects of intraperitoneal and intracerebroventricular administration of the GABAB receptor antagonist CGP 35348 on food intake in rats. European Journal of Pharmacology 2004, 503:89-93.
39. Pattij T., Janssen M.C., Schepers I., González-Cuevas G., de Vries T.J., Schoffelmeer A.N. Effects of the cannabinoid CB1 receptor antagonist rimonabant on distinct measures of impulsive behavior in rats. Psychopharmacology (Berl) 2007, 193:85-96.
40. Paxinos G., Watson Ch. The rat brain in stereotaxic coordinates 2007, Amsterdam, Elsevier.
41. Peles E., Schreiber S., Sutzman A., Adelson M. Attention deficit hyperactivity disorder and obsessive-compulsive disorder among former heroin addicts currently in methadone maintenance treatment. Psychopathology 2012, 45:327-333.
42. Perry J.L., Carroll M.E. The role of impulsive behavior in drug abuse. Psychopharmacology (Berl) 2008, 200:1-26.
43. Quinn P.D., Harden K.P. Differential changes in impulsivity and sensation seeking and the escalation of substance use from adolescence to early adulthood. Developments and Psychopathology 2012, 24:1-17.
44. Rodriguez J.S., Boctor S.Y., Flores L.C., Phelix C.F., Martinez J.L. Local pretreatment with the cannabinoid CB1 receptor antagonist AM251 attenuates methamphetamine intra-accumbens self-administration. Neuroscience Letters 2011, 489:187-191.
45. Rueda-Orozco P., Montes-Rodríguez C.J., Soria-Gomez E., Méndez-Díaz M., Prospéro-García O. Impairment of endocannabinoids activity in the dorsolateral striatum delays extinction of behavior in a procedural memory task in rats. Neuropharmacology 2008, 55:55-62.
46. Sarviharju M., Riikonen J., Jaatinen P., Sinclair D., Hervonen A., Kiianmaa K. Survival of AA and ANA rats during lifelong ethanol exposure. Alcoholism: Clinical and Experimental Research. 2004, 28:93-97.
47. Schlicker E., Kathmann M. Modulation of transmitter release via presynaptic cannabinoid receptors. Trends in Pharmacological Sciences 2001, 22:565-572.
48. Shoaib M. The cannabinoid antagonist AM251 attenuates nicotine self-administration and nicotine-seeking behavior in rats. Neuropharmacology 2008, 54:438-444.
49. Solowij N., Jones K.A., Rozman M.E., Davis S.M., Ciarrochi J., Heaven P.C., et al. Reflection impulsivity in adolescent cannabis users: a comparison with alcohol-using and non-substance-using adolescents. Psychopharmacology 2012, 219:575-586.
50. Soria-Gómez E., Guzmán K., Pech-Rueda O., Montes-Rodriguez C.J., Cisneros M., Prospéro-García O. Oleylethanolamide affects food intake and sleep-waking cycle through a hypothalamic modulation. Pharmacological Research 2010, 61:379-384.
51. Stanley B.G., Urstadt K.R., Charles J.R., Kee T. Glutamate and GABA in lateral hypothalamic mechanisms controlling food intake. Physiology and Behavior 2011, 104:40-46.
52. Svízenská I., Dubový P., Sulcová A. Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures a short review. Pharmacology Biochemistry and Behavior 2008, 90:501-511.
53. Thanos P.K., Dimitrakakis E.S., Rice O., Gifford A., Volkow N.D. Ethanol self-administration and ethanol conditioned place preference are reduced in mice lacking cannabinoid CB1 receptors. Behavioural Brain Research 2005, 64:206-213.
54. Urcelay G.P., Dalley J.W. Linking ADHD, impulsivity, and drug abuse: a neuropsychological perspective. Current Topics in Behavioral Neurosciences 2012, 9:173-197.
55. Van Waes V., Enache M., Berton O., Vinner E., Lhermitte M., Maccari S., et al. Effect of prenatal stress on alcohol preference and sensitivity to chronic alcohol exposure in male rats. Psychopharmacology 2011, 214:197-208.
56. Verdejo-García A., Lawrence A.J., Clark L. Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neuroscience & Biobehavioral Review 2008, 32:777-810.
57. Ward S.J., Rosenberg M., Dykstra L.A., Walker E.A. The CB1 antagonist rimonabant (SR 141716) blocks cue-induced reinstatement of cocaine seeking and other context and extinction phenomena predictive of relapse. Drug and Alcohol Dependence 2009, 105:248-255.
58. WHO. http://www.who.int/es/.
59. Wilson R.I., Nicoll R.A. Endocannabinoid signaling in the brain. Science 2002, 296:678-682.
60. 2 receptors modulate cocaine's actions in mice. Nature Neuroscience 2011, 14:1160-1166.
61. Zahr N.M., Mayer D., Rohlfing T., Hasak M.P., Hsu O., Vinco S., et al. Brain injury and recovery following binge ethanol: evidence from in vivo magnetic resonance spectroscopy. Biological Psychiatry 2010, 67:846-854.